Results for “ ”

Entry Author Date Location
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Creating Consistent Value in Biotech Without Diluting Stakeholders 04/07/20 National
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic 04/03/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus 03/31/20 Europe
Sanofi Adds mRNA COVID-19 Vaccine Bet Through Translate Bio Alliance 03/27/20 Europe
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics 03/25/20 Europe
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
Qiagen Juices RNA Extraction Kit Capacity to Feed Coronavirus Test Needs 03/17/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund 03/11/20 Europe
Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod 03/09/20 Europe
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Sanofi Wins FDA Nod for Combo Therapy in Multiple Myeloma 03/03/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Esperion’s FDA-Approved Cholesterol Drug Priced Even Lower Than Expected 02/24/20 Detroit Ann Arbor
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Page 2 of 3 « previous page · next page »